Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Physiol Lung Cell Mol Physiol ; 310(11): L1088-97, 2016 06 01.
Article in English | MEDLINE | ID: mdl-27036867

ABSTRACT

The SU5416 + hypoxia (SuHx) rat model is a commonly used model of severe pulmonary arterial hypertension. While it is known that exposure to hypoxia can be replaced by another type of hit (e.g., ovalbumin sensitization) it is unknown whether abnormal pulmonary blood flow (PBF), which has long been known to invoke pathological changes in the pulmonary vasculature, can replace the hypoxic exposure. Here we studied if a combination of SU5416 administration combined with pneumonectomy (PNx), to induce abnormal PBF in the contralateral lung, is sufficient to induce severe pulmonary arterial hypertension (PAH) in rats. Sprague Dawley rats were subjected to SuPNx protocol (SU5416 + combined with left pneumonectomy) or standard SuHx protocol, and comparisons between models were made at week 2 and 6 postinitiation. Both SuHx and SuPNx models displayed extensive obliterative vascular remodeling leading to an increased right ventricular systolic pressure at week 6 Similar inflammatory response in the lung vasculature of both models was observed alongside increased endothelial cell proliferation and apoptosis. This study describes the SuPNx model, which features severe PAH at 6 wk and could serve as an alternative to the SuHx model. Our study, together with previous studies on experimental models of pulmonary hypertension, shows that the typical histopathological findings of PAH, including obliterative lesions, inflammation, increased cell turnover, and ongoing apoptosis, represent a final common pathway of a disease that can evolve as a consequence of a variety of insults to the lung vasculature.


Subject(s)
Hypertension, Pulmonary/pathology , Animals , Blood Pressure , Disease Models, Animal , Hypertension, Pulmonary/etiology , Indoles , Male , Pneumonectomy , Pyrroles , Rats, Sprague-Dawley
2.
Vascul Pharmacol ; 83: 17-25, 2016 08.
Article in English | MEDLINE | ID: mdl-26804008

ABSTRACT

In pulmonary arterial hypertension (PAH) structural and functional abnormalities of the small lung vessels interact and lead to a progressive increase in pulmonary vascular resistance and right heart failure. A current pathobiological concept characterizes PAH as a 'quasi-malignant' disease focusing on cancer-like alterations in endothelial cells (EC) and the importance of their acquired apoptosis-resistant, hyper-proliferative phenotype in the process of vascular remodeling. While changes in pulmonary blood flow (PBF) have been long-since recognized and linked to the development of PAH, little is known about a possible relationship between an altered PBF and the quasi-malignant cell phenotype in the pulmonary vascular wall. This review summarizes recognized and hypothetical effects of an abnormal PBF on the pulmonary vascular bed and links these to quasi-malignant changes found in the pulmonary endothelium. Here we describe that abnormal PBF does not only trigger a pulmonary vascular cell growth program, but may also maintain the cancer-like phenotype of the endothelium. Consequently, normalization of PBF and EC response to abnormal PBF may represent a treatment strategy in patients with established PAH.


Subject(s)
Endothelial Cells/pathology , Hypertension, Pulmonary/pathology , Hypertension, Pulmonary/physiopathology , Neoplasms/pathology , Pulmonary Artery/pathology , Pulmonary Artery/physiopathology , Pulmonary Circulation , Angiogenic Proteins/metabolism , Animals , Apoptosis , Cell Proliferation , Endothelial Cells/metabolism , Energy Metabolism , Humans , Hypertension, Pulmonary/metabolism , Mechanotransduction, Cellular , Neoplasms/metabolism , Neovascularization, Pathologic , Phenotype , Pulmonary Artery/metabolism , Regional Blood Flow , Stress, Mechanical
3.
Circulation ; 120(1): 42-9, 2009 Jul 07.
Article in English | MEDLINE | ID: mdl-19546388

ABSTRACT

BACKGROUND: Exercise training in pulmonary arterial hypertension (PH) is a promising adjunct to medical treatment. However, it is still unclear whether training is beneficial for all PH patients. We hypothesized that right ventricular adaptation plays a pivotal role in the response to training. METHODS AND RESULTS: Two different dosages of monocrotaline were used in rats to model stable PH with preserved cardiac output and progressive PH developing right heart failure. Two weeks after injection, PH was confirmed by echocardiography, and treadmill training was initiated. Rats were trained for 4 weeks unless manifest right heart failure developed earlier. At the end of the study protocol, all rats were functionally assessed by endurance testing, echocardiography, and invasive pressure measurements. Lungs and hearts were further analyzed in quantitative histomorphologic analyses. In stable PH, exercise training was well tolerated and markedly increased exercise endurance (from 25+/-3.9 to 62+/-3.9 minutes; P<0.001). Moreover, capillary density increased significantly (from 1.21+/-0.12 to 1.51+/-0.07 capillaries per cardiomyocyte; P<0.05). However, in progressive PH, exercise training worsened survival (hazard ratio, 2.7; 95% confidence interval, 1.1 to 14.2) and increased pulmonary vascular remodeling. In addition, training induced widespread leukocyte infiltration into the right ventricle (from 135+/-14 to 276+/-18 leukocytes per 1 mm(2); P<0.001). CONCLUSIONS: In our rat model, exercise training was found to be beneficial in stable PH but detrimental in progressive PH. Future studies are necessary to address the clinical implications of our findings.


Subject(s)
Adaptation, Physiological/physiology , Heart Failure/physiopathology , Heart Failure/therapy , Hypertension, Pulmonary/physiopathology , Hypertension, Pulmonary/therapy , Physical Conditioning, Animal/physiology , Animals , Biopsy , Capillaries/physiology , Cardiac Catheterization , Cardiac Output/physiology , Coronary Circulation/physiology , Disease Models, Animal , Disease Progression , Echocardiography , Heart Failure/diagnosis , Hypertension, Pulmonary/chemically induced , Male , Monocrotaline/toxicity , Myocarditis/physiopathology , Physical Endurance/physiology , Rats , Rats, Wistar , Rest , Survival Rate
SELECTION OF CITATIONS
SEARCH DETAIL
...